Refine your search
Availability
-
Authors
-
Topics
- Antibodies, Monoclonal
- Antineoplastic Agents, Immunological
- Bevacizumab
- Cetuximab
- Colorectal Neoplasms
- Cost-Benefit Analysis
- Czech Republic
- Drug Costs
- Economics, Pharmaceutical
- ErbB Receptors
- Humans
- Neoplasm Metastasis
- Panitumumab
- Quality-Adjusted Life Years
- Retrospective Studies
- Survival Rate
- Treatment Outcome
- antagonists & inhibitors
- drug therapy
- economics
- Show more
- Show less
-
Languages